A PHASE 1/2 STUDY OF REGN5093 IN PATIENTS WITH MET-ALTERED ADVANCED NON-SMALL CELL LUNG CANCER

Clinical Trial Grant

Duke Scholars

Principal Investigator Thomas Eldridge Stinchcombe Medicine, Medical Oncology

Administered By

Duke Cancer Institute

Awarded By

Regeneron Pharmaceuticals, Inc.

Start Date

January 2, 2020

End Date

December 15, 2020

Administered By

Duke Cancer Institute

Awarded By

Regeneron Pharmaceuticals, Inc.

Start Date

January 2, 2020

End Date

December 15, 2020